Vaccine Downstream processing –an overview...Title or Job Number | XX Month 201X 21 ~90 µm...

26
Imagination at work Vaccine Downstream processing –an overview Mia Bennemo May, 2015

Transcript of Vaccine Downstream processing –an overview...Title or Job Number | XX Month 201X 21 ~90 µm...

Page 1: Vaccine Downstream processing –an overview...Title or Job Number | XX Month 201X 21 ~90 µm chromatography bead 100 nm influenza virus 200 x 500 nm Pox virus 1-7 nm proteins Diffusion

Imagination at work

Vaccine Downstream processing –an overview Mia Bennemo May, 2015

Page 2: Vaccine Downstream processing –an overview...Title or Job Number | XX Month 201X 21 ~90 µm chromatography bead 100 nm influenza virus 200 x 500 nm Pox virus 1-7 nm proteins Diffusion

See tutorial regarding confidentiality disclosures. Delete if not needed.

Overview

• Vaccines overview

• Demands on vaccine purification

• Common techniques for vaccine purification

• Example of a purification process

• Summary

Vaccine Downstream processing – an overview| May 2015 2

Page 3: Vaccine Downstream processing –an overview...Title or Job Number | XX Month 201X 21 ~90 µm chromatography bead 100 nm influenza virus 200 x 500 nm Pox virus 1-7 nm proteins Diffusion

Vaccine Overview

Page 4: Vaccine Downstream processing –an overview...Title or Job Number | XX Month 201X 21 ~90 µm chromatography bead 100 nm influenza virus 200 x 500 nm Pox virus 1-7 nm proteins Diffusion

See tutorial regarding confidentiality disclosures. Delete if not needed.

Cell culture / Fermentation

Purification

Fill and Finish

Analysis (QC/QA)

The

Vacc

ines

Virus based

Protein based

The

Man

ufac

turi

ng p

roce

ss

Polysaccharide based

DNA based

Bacteria based

How Vaccines are manufactured

Number and order of the different steps depends on the specific vaccine production

Vaccine Downstream processing – an overview May 2015

Page 5: Vaccine Downstream processing –an overview...Title or Job Number | XX Month 201X 21 ~90 µm chromatography bead 100 nm influenza virus 200 x 500 nm Pox virus 1-7 nm proteins Diffusion

Demands on vaccine purification

Page 6: Vaccine Downstream processing –an overview...Title or Job Number | XX Month 201X 21 ~90 µm chromatography bead 100 nm influenza virus 200 x 500 nm Pox virus 1-7 nm proteins Diffusion

See tutorial regarding confidentiality disclosures. Delete if not needed.

Safety and quality is priority

Regulatory requirements

• Safe vaccine with no or minimal adverse effects

• Effective dose

• Stability

• Process control

• Reproducable process

6 Vaccine Downstream processing – an overview| May 2015

Page 7: Vaccine Downstream processing –an overview...Title or Job Number | XX Month 201X 21 ~90 µm chromatography bead 100 nm influenza virus 200 x 500 nm Pox virus 1-7 nm proteins Diffusion

Downstream purification of vaccines

Page 8: Vaccine Downstream processing –an overview...Title or Job Number | XX Month 201X 21 ~90 µm chromatography bead 100 nm influenza virus 200 x 500 nm Pox virus 1-7 nm proteins Diffusion

See tutorial regarding confidentiality disclosures. Delete if not needed.

Downstream processing of viruses Available technologies

Harvest • Lytic virus • Non-lytic virus

• Detergent

• Mechanical disruption / Homogenization

• Osmotic shock

• Freeze-thaw

8

Cell culture

Harvest

Clarification

Primary purification

Secondary Purification

Formulation

Vaccine Downstream processing – an overview| May 2015

Page 9: Vaccine Downstream processing –an overview...Title or Job Number | XX Month 201X 21 ~90 µm chromatography bead 100 nm influenza virus 200 x 500 nm Pox virus 1-7 nm proteins Diffusion

See tutorial regarding confidentiality disclosures. Delete if not needed.

Impurity challenges after lysis

9

Cell lysis

Organelles/cell membrane /lipids

Antigen (e.g. virus)

chemicals

DNA/RNA

proteins

Vaccine Downstream processing – an overview| May 2015

Page 10: Vaccine Downstream processing –an overview...Title or Job Number | XX Month 201X 21 ~90 µm chromatography bead 100 nm influenza virus 200 x 500 nm Pox virus 1-7 nm proteins Diffusion

See tutorial regarding confidentiality disclosures. Delete if not needed.

Goal with purification

10

Cell lysis

Antigen (e.g. virus)

Purification

Vaccine Downstream processing – an overview| May 2015

Page 11: Vaccine Downstream processing –an overview...Title or Job Number | XX Month 201X 21 ~90 µm chromatography bead 100 nm influenza virus 200 x 500 nm Pox virus 1-7 nm proteins Diffusion

See tutorial regarding confidentiality disclosures. Delete if not needed.

Downstream processing of viruses Available technologies

Clarification • Filtration

– Normal flow – Tangential flow

• Centrifugation

11

Cell culture

Harvest

Clarification

Primary purification

Secondary Purification

Formulation

Vaccine Downstream processing – an overview| May 2015

Page 12: Vaccine Downstream processing –an overview...Title or Job Number | XX Month 201X 21 ~90 µm chromatography bead 100 nm influenza virus 200 x 500 nm Pox virus 1-7 nm proteins Diffusion

See tutorial regarding confidentiality disclosures. Delete if not needed.

Normal flow filtration

• Removal of cell debris and larger particulates

• Porosities from 0.2 - 20 µm

• Scalable

• Single-use

• Straight forward process set up

• Not recommended for harvest with high particulate content

12

Feed Flow

Filtrate Flow

Vaccine Downstream processing – an overview| May 2015

Page 13: Vaccine Downstream processing –an overview...Title or Job Number | XX Month 201X 21 ~90 µm chromatography bead 100 nm influenza virus 200 x 500 nm Pox virus 1-7 nm proteins Diffusion

See tutorial regarding confidentiality disclosures. Delete if not needed.

Downstream processing of viruses Available technologies

Primary purification • Tangential flow filtration (TFF) • Density gradient centrifugation • Precipitation • Chromatography

13

Cell culture

Harvest

Clarification

Primary purification

Secondary Purification

Formulation

Vaccine Downstream processing – an overview| May 2015

Page 14: Vaccine Downstream processing –an overview...Title or Job Number | XX Month 201X 21 ~90 µm chromatography bead 100 nm influenza virus 200 x 500 nm Pox virus 1-7 nm proteins Diffusion

See tutorial regarding confidentiality disclosures. Delete if not needed.

Tangential flow filtration

Cross flow

Permeate flow

Vaccine Downstream processing – an overview| May 2015

• Sweeping effect clean filter surface • Allow greater throughput on smaller surface area

Feed pressure

RETENTATE PRESSURE

Permeate, (Filtrate)

BACKPRESSURE VALVE

RECIRCULATION PUMP

Feed Reservoir

( concentrate )

UF or MF Device

Dilute Feed Material

Page 15: Vaccine Downstream processing –an overview...Title or Job Number | XX Month 201X 21 ~90 µm chromatography bead 100 nm influenza virus 200 x 500 nm Pox virus 1-7 nm proteins Diffusion

See tutorial regarding confidentiality disclosures. Delete if not needed.

• Hollow fiber cartridge consists of tubular fibers • Concentration/ diafiltration • Microfiltration • Suitable for shear sensitive material • Possible handle high particle loads (ex cell harvest) • Defined pore sizes • Re-usable • Scalable

Tangential flow filtration

15

• Cassettes consists of sheet membranes • Concentration/ diafiltration • Defined pore sizes • Re-usable • Scalable

Hollow fiber filters Flat sheet cassettes

Vaccine Downstream processing – an overview| May 2015

Page 16: Vaccine Downstream processing –an overview...Title or Job Number | XX Month 201X 21 ~90 µm chromatography bead 100 nm influenza virus 200 x 500 nm Pox virus 1-7 nm proteins Diffusion

See tutorial regarding confidentiality disclosures. Delete if not needed.

Downstream processing of viruses Available technologies

Secondary purification • Density gradient

centrifugation • Selective precipitation • Chromatography

– IEX, MM, AC, HIC, SEC – Bead format (Packed bed) – Membrane format (Capsule)

16

Cell culture

Harvest

Clarification

Primary purification

Secondary purification

Formulation

Vaccine Downstream processing – an overview| May 2015

Page 17: Vaccine Downstream processing –an overview...Title or Job Number | XX Month 201X 21 ~90 µm chromatography bead 100 nm influenza virus 200 x 500 nm Pox virus 1-7 nm proteins Diffusion

See tutorial regarding confidentiality disclosures. Delete if not needed.

Ion exchange chromatography

17 Vaccine Downstream processing – an overview| May 2015

Surf

ace

net c

harg

e Cation

Anion

pH

Anion exchange chromatography

• (-) Negatively charged molecules binds to (+) positively charged ligands

Cation exchange chromatography

• (+) Positively charged molecules binds to (-) negatively charged ligands

Page 18: Vaccine Downstream processing –an overview...Title or Job Number | XX Month 201X 21 ~90 µm chromatography bead 100 nm influenza virus 200 x 500 nm Pox virus 1-7 nm proteins Diffusion

See tutorial regarding confidentiality disclosures. Delete if not needed.

Hydrophobic interaction chromatography

18 Vaccine Downstream processing – an overview| May 2015

Separation by hydrophobicity

• Hydrophobic surfaces of proteins interact with the ligand in precence of salts

• High salt content enhance and low salt weakens the interaction

Page 19: Vaccine Downstream processing –an overview...Title or Job Number | XX Month 201X 21 ~90 µm chromatography bead 100 nm influenza virus 200 x 500 nm Pox virus 1-7 nm proteins Diffusion

See tutorial regarding confidentiality disclosures. Delete if not needed.

Size exclusion chromatography

19

Exluded from pores

Enter a fraction of the pores

Enter all pores

Abso

rban

ce Sample injection

High molecular

weight

Intermediate molecular

weight Low molecular

weight

Vaccine Downstream processing – an overview| May 2015

Page 20: Vaccine Downstream processing –an overview...Title or Job Number | XX Month 201X 21 ~90 µm chromatography bead 100 nm influenza virus 200 x 500 nm Pox virus 1-7 nm proteins Diffusion

See tutorial regarding confidentiality disclosures. Delete if not needed.

Affinity chromatography

20 Vaccine Downstream processing – an overview| May 2015

Specific binding

Few affinity resins available for vaccines

• Agarose based affinity resin for adeno associated virus

• Pseudo affinity resins for influenza – sulphated cellulose

– sulphated dextrane

Page 21: Vaccine Downstream processing –an overview...Title or Job Number | XX Month 201X 21 ~90 µm chromatography bead 100 nm influenza virus 200 x 500 nm Pox virus 1-7 nm proteins Diffusion

See tutorial regarding confidentiality disclosures. Delete if not needed.

Chromatograpic purification of large molecules can be challenging

Title or Job Number | XX Month 201X

21

~90 µm chromatography bead

100 nm influenza virus

200 x 500 nm Pox virus

1-7 nm proteins

Diff

usio

n co

nsta

nt

25 nm polio virus

Flow through chromatography recomended

Bind-Elute chromatography possible

Vaccine Downstream processing – an overview| May 2015

Pores

Page 22: Vaccine Downstream processing –an overview...Title or Job Number | XX Month 201X 21 ~90 µm chromatography bead 100 nm influenza virus 200 x 500 nm Pox virus 1-7 nm proteins Diffusion

See tutorial regarding confidentiality disclosures. Delete if not needed.

• Host cell proteins and DNA fragments bind to the core and viruses stay in the void.

Core bead chromatography

22 Vaccine Downstream processing – an overview| May 2015

Page 23: Vaccine Downstream processing –an overview...Title or Job Number | XX Month 201X 21 ~90 µm chromatography bead 100 nm influenza virus 200 x 500 nm Pox virus 1-7 nm proteins Diffusion

See tutorial regarding confidentiality disclosures. Delete if not needed.

Process example

23

Polio IPV

Seed N-2 Cell

expansion

Seed N-1 Cell

expansion

Production bioreactor

Virus propagation

Clarification NFF

Removal of cell debris and large particles

TFF Conc of

polio virus

SEC Separation

of polio virus from

small molecular

compounds

AIEX (FT) DNA

removal. Polio virus

in flow through

Virus inactivation

formaldehyde

Formulation Sterile

filtration, mixing with

other strains

Vaccine Downstream processing – an overview| May 2015

Page 24: Vaccine Downstream processing –an overview...Title or Job Number | XX Month 201X 21 ~90 µm chromatography bead 100 nm influenza virus 200 x 500 nm Pox virus 1-7 nm proteins Diffusion

See tutorial regarding confidentiality disclosures. Delete if not needed.

Summary

• Robust downstream process can ensure consistent high quality

• Most vaccines have unique purification processes

• Preferably use scalable techniques when developing new processes

• Purification of particles in binding mode can be difficult with classic chromatography

• Core bead chromatography suitable for purification of particles of sufficient size

24 Vaccine Downstream processing – an overview| May 2015

Page 25: Vaccine Downstream processing –an overview...Title or Job Number | XX Month 201X 21 ~90 µm chromatography bead 100 nm influenza virus 200 x 500 nm Pox virus 1-7 nm proteins Diffusion

See tutorial regarding confidentiality disclosures. Delete if not needed.

Thank you

25

GE Healthcare Bio-Sciences AB, a General Electric company. GE Healthcare Bio-Sciences AB Björkgatan 30 751 84 Uppsala Sweden GE, imagination at work and GE monogram are trademarks of General Electric Company. All goods and services are sold subject to the terms and conditions of sale of the company within GE Healthcare which supplies them. A copy of these terms and conditions is available on request. Contact your local GE Healthcare representative for the most current information. © 2015 General Electric Company – All rights reserved.

Vaccine Downstream processing – an overview| May 2015

Page 26: Vaccine Downstream processing –an overview...Title or Job Number | XX Month 201X 21 ~90 µm chromatography bead 100 nm influenza virus 200 x 500 nm Pox virus 1-7 nm proteins Diffusion